GENELUX Corp
GNLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001231457
In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $194.3K in total
- 7
- 13F holdersQ2 2026, +1 vs. previous quarter
- 72
- 13F valueReported value at the end of Q2 2026
- $29.5M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding GNLX, Q2 2026
No superinvestor reported holding GNLX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by GENELUX Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)7:05 PM ET | Aug 31 | 2 days | Cappello JosephChief Technical Officer | SSale | −10.3K | $2.74 | −$28.1K | −3.1%318.5K after | |
| Sep 2, 2026 (view filing)7:05 PM ET | Aug 31 | 2 days | Zindrick ThomasPresident and CEO | SSale | −34.5K | $2.67 | −$91.9K | −2.7%1.23M after | |
| Sep 2, 2026 (view filing)7:05 PM ET | Aug 31 | 2 days | Yu TonyChief Scientific Officer | SSale | −9.68K | $2.75 | −$26.7K | −3.6%258.7K after | |
| Aug 4, 2026 (view filing)8:20 PM ET | Aug 4 | Same day | Yu TonyChief Scientific Officer | SSale | −653 | $2.94 | −$1.92K | −0.2%268.4K after | |
| Aug 4, 2026 (view filing)8:20 PM ET | Aug 4 | Same day | Cappello JosephChief Technical Officer | SSale | −653 | $2.95 | −$1.92K | −0.2%328.7K after | |
| Aug 4, 2026 (view filing)8:20 PM ET | Aug 4 | Same day | Zindrick ThomasPresident and CEO | SSale | −3.02K | $2.95 | −$8.91K | −0.2%1.26M after | |
| Jul 2, 2026 (view filing)4:35 PM ET | Jul 1 | 1 day | Smither John WDirector | SSale | −12.0K | $2.91 | −$34.9K | −11.6%91.4K after | |
| Jun 4, 2026 (view filing) | Jun 3 | 1 day | Smalling RalphHead of Regulatory | SSale | −192 | $2.93 | −$562.56 | −0.3%67.6K after | |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Thomas JohnDirector | SSale | −10.0K | $2.98 | −$29.8K | −2.1%472.8K after | 10b5-1 |
| May 12, 2026 (view filing) | May 11 | 1 day | Cappello JosephChief Technical Officer | SSale | −605 | $2.97 | −$1.80K | −0.4%154.5K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in GENELUX Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodward Diversified Capital, LLC | 2,262,108 | $6.81M | 3.00% | +144,925+6.8% | Added |
| Vanguard Capital Management LLC | 1,677,724 | $5.05M | 0.00% | −17,756−1.0% | Reduced |
| Bleichroeder LP | 1,380,666 | $4.16M | 0.74% | 00.0% | Unchanged |
| BlackRock, Inc. | 439,602 | $1.32M | 0.00% | +33,730+8.3% | Added |
| Geode Capital Management, LLC | 439,213 | $1.32M | 0.00% | −14,548−3.2% | Reduced |
| CM Management, LLC | 400,000 | $1.20M | 0.76% | +150,000+60.0% | Added |
| Bank of America Corp | 328,803 | $989.7K | 0.00% | +4,938+1.5% | Added |
| Vanguard Fiduciary Trust Co | 236,344 | $711.4K | 0.00% | −15,266−6.1% | Reduced |
| Flputnam Investment Management Co | 231,405 | $696.5K | 0.01% | −49,499−17.6% | Reduced |
| Global Retirement Partners, LLC | 227,854 | $685.8K | 0.01% | +227,854 | New |